Health inequities in the rheumatic diseases of childhood

被引:3
作者
Falkenstein, Danielle K. [1 ]
Jarvis, James N. [2 ,3 ]
机构
[1] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14203 USA
[2] Univ Buffalo, Dept Pediat, Buffalo, NY 14203 USA
[3] Univ Buffalo, Genet Genom & Bioinformat Program, Buffalo, NY 14203 USA
关键词
adverse childhood experiences; health inequities; pediatric rheumatic disease; SYSTEMIC-LUPUS-ERYTHEMATOSUS; JUVENILE IDIOPATHIC ARTHRITIS; AMERICAN-INDIANS; EXPERIENCES; ADVERSE; POPULATION; PREVALENCE; OUTCOMES; DERMATOMYOSITIS; ONSET;
D O I
10.1097/BOR.0000000000000893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To describe differences in disease manifestations and outcomes in pediatric rheumatic diseases as they occur in non-European-descended populations in North America. Recent findings Differences in disease prevalence, clinical phenotypes, disease course, and outcomes have been described across the spectrum of pediatric-onset rheumatic diseases. Although these differences are commonly explained by differences in genetic risk or access to tertiary healthcare facilities, our emerging understanding of the immunobiology of historical/ongoing trauma suggest a more complex explanation for these observed differences. Health inequities as observed in pediatric rheumatic diseases are likely to emerge from a complex interplay between social and biological factors. The important contribution of historical and repetitive trauma deserves further exploration.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 50 条
  • [31] Oral health in patients with rheumatic diseases
    Calderin, Omarys Chang
    Hutado, Carlos Alberto Alban
    REVISTA CUBANA DE REUMATOLOGIA, 2022, 24 (03):
  • [32] Use of biologics in the treatment of childhood rheumatic diseases.
    Arkachaisri T.
    Lehman T.J.
    Current Rheumatology Reports, 2000, 2 (4) : 330 - 336
  • [33] Safety evaluations of adalimumab for childhood chronic rheumatic diseases
    Maccora, Ilaria
    dell'Anna, Maria Pia
    Vannacci, Alfredo
    Simonini, Gabriele
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (06) : 661 - 671
  • [34] Rheumatic diseases in childhood and adolescence: importance of early multi-professional care
    Sengler, Claudia
    Niewerth, Martina
    Minden, Kirsten
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2020, 63 (07) : 846 - 855
  • [35] Biosimilars in childhood chronic rheumatic diseases: friend or foe?
    Maccora, Ilaria
    Simonini, Gabriele
    LANCET RHEUMATOLOGY, 2024, 6 (07) : e413 - e414
  • [36] Onset to first visit intervals in childhood rheumatic diseases
    Shapiro, Cal
    Maenz, Lynn
    Hossain, Md. Alonigir
    Pahwa, Punam
    Rosenberg, Alan
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (09) : 1913 - 1917
  • [37] Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations
    Yujuan Zhang
    Diana Milojevic
    Pediatric Drugs, 2017, 19 : 193 - 211
  • [38] Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases
    Edens, Cuoghi
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2022, 48 (01) : 91 - 112
  • [39] The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases
    Ringold, Sarah
    Nigrovic, Peter A.
    Feldman, Brian M.
    Tomlinson, George A.
    von Scheven, Emily
    Wallace, Carol A.
    Huber, Adam M.
    Schanberg, Laura E.
    Li, Suzanne C.
    Weiss, Pamela F.
    Fuhlbrigge, Robert C.
    Morgan, Esi M.
    Kimura, Yukiko
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (05) : 669 - 678
  • [40] Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations
    Zhang, Yujuan
    Milojevic, Diana
    PEDIATRIC DRUGS, 2017, 19 (03) : 193 - 211